Prostate Power Play: Does Accelerate -Deficient Cancer Progression?

Triscott, Joanna; Rubin, Mark A. (2018). Prostate Power Play: Does Accelerate -Deficient Cancer Progression? Cancer discovery, 8(6), pp. 682-685. American Association for Cancer Research 10.1158/2159-8290.CD-18-0369

[img] Text
682.full.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (2MB)

PI3K pathway alterations are frequently recurrent in metastatic prostate cancer and are associated with the development of currently incurable castration-resistant disease. Candidate inhibitors that target single PI3K pathway members lack efficacy as demonstrated in multiple clinical trials. In this issue, Pearson and colleagues examine the functional importance of co-occurring and aberrations using a novel mouse model and demonstrate a synergistic acceleration of tumorigenesis that may be responsible for metastatic prostate cancer. .

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Präzisionsonkologie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Präzisionsonkologie

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR)

UniBE Contributor:

Triscott, Joanna Catherine Caprio, Rubin, Mark Andrew

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2159-8290

Publisher:

American Association for Cancer Research

Language:

English

Submitter:

Marla Rittiner

Date Deposited:

17 Dec 2019 13:06

Last Modified:

05 Dec 2022 15:25

Publisher DOI:

10.1158/2159-8290.CD-18-0369

PubMed ID:

29858226

BORIS DOI:

10.7892/boris.125522

URI:

https://boris.unibe.ch/id/eprint/125522

Actions (login required)

Edit item Edit item
Provide Feedback